Comment on safety and efficacy of oral lopinavir/ritonavir in pediatric patients with coronavirus disease: a nationwide comparative analysis

Eur Rev Med Pharmacol Sci. 2021 Mar;25(6):2473-2474. doi: 10.26355/eurrev_202103_25408.NO ABSTRACTPMID:33829431 | DOI:10.26355/eurrev_202103_25408

Source: European Review for Medical and Pharmacological Sciences - April 8, 2021 Category: Drugs & Pharmacology Authors: M Ceccarelli P Pavone E Venanzi Rullo G Nunnari Source Type: research